Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.100
-0.030 (-2.65%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $64.06 million as of October 16, 2026. It is the 28,458th most valuable company in the world and the 4,460th biggest in the United States. Its market cap has decreased by 54.28% in one year.
Market Cap
64.06M
Enterprise Value
15.33M
1-Year Change
-54.28%
Global Rank
Country Rank
#4,460 United States
Category
ChartMarket Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $64.06M, a decrease of -58.43%. That is a compound annual growth rate of -9.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 64.10M | -51.18% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 67.11M |
| MAIA Biotechnology | 66.91M |
| Champions Oncology | 65.42M |
| XBiotech | 64.63M |
| Oncolytics Biotech | 63.51M |
| Cingulate | 63.40M |
| Biomea Fusion | 62.98M |
| Fortress Biotech | 62.37M |